Brand-name drugs that treat cardiovascular conditions don't work any better than their cheaper generic counterparts, according to a study headed by Dr. Aaron Kesselheim of Brigham and Women's Hospital
and Harvard Medical School. "Without today's innovative brand-name drugs to legally copy, there would be no generic drug industry," the Pharmaceutical Research and Manufacturers of America,
responds in a statement.
Read the whole story at Fox News/Reuters »
